Strategy Driven

MARCH 18, 2011

In addition, we believe that your starting point for strategy development is what you are already great at, rather than studying the industry and market for opportunities. Is it more important to consider capabilities when you develop a strategy now than it was, say, five years ago? SD : Why now? What do most companies do instead?

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

SEPTEMBER 21, 2018

This isn’t all that surprising given the level of innovation activity in these sectors, but directors operating in similarly disrupted sectors should take note. Just over one-fifth (22%) of boards operating in the IT and telecom industry sought tech expertise when filling their most recent board seat, higher than in any other industry.

Innovation 11

Innovation Short-term Telecommunications Long-term 11

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 25, 2018

In fact, both the sectoral and the geographic diversity of superstar firms is greater today than 20 years ago. These “superstar” sectors include financial services such as banking, insurance, and asset management, professional services, internet and software, real estate, and pharmaceuticals and medical products.

Industry 13

Industry Company GDP Bottom-up 13

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. ” CEOs also worried about whether their high potential employees were being properly developed. Operating in a Global Marketplace. One area that proved especially challenging was mobility.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 23, 2017

The key to building predictive models is knowing what you want to predict and collecting large and diverse data sets that may enable you to do so. At EY, where some of us work, we have developed a tool for social media analytics called SMAART that is able to understand sentiment within consumer and influencer groups. Build a Dashboard.

Company 8

Company Management Metrics Tools 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Where only the largest organizations could operate 24-hour call centers, today, even small organizations have access to companies like Global Response.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JULY 30, 2015

After interviewing several ad agency executives and marketing leaders in a diverse group of businesses — pharmaceutical, high-tech, manufacturing, retail, sports, and others — I’ve found a few common themes that could help explain what is going on. Agencies are slow. Who owns the data? This must be kept in-house.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

DECEMBER 5, 2016

It serves vastly diverse populations: toddlers and caregivers, new immigrants, lifelong learners, famous novelists, and scholars. How to provide hyper-local services tailored to the diverse needs of its patrons while also upholding a consistent and high standard of service? in less than five years. in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. Many innovative ideas became the victims of in-fighting among managers who had competing objectives.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 28, 2017

Smart businesspeople are well aware that a deceptive firm will quickly develop a bad reputation and lose repeat and future business. Doing so entails operating more efficiently or innovating to create products that consumers value more. What processes led to the development and delivery of a given product or service?

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. It also took into account their roles in changing patient behavior.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

JUNE 24, 2015

Managers and other business leaders face a dilemma: with increasingly diverse environments to manage and rising stakes to get it right, how do they identify the most effective approach to business strategy and marshal the right thinking and behaviors to conceive and execute it, supported by the appropriate frameworks and tools?

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. A portfolio approach can take many forms.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

AUGUST 23, 2016

Boards of companies operating in the consumer discretionary industry have a disproportionately high representation of Democrats, while boards operating in the industrials and energy and utilities industries skew more Republican. Overall, directors from both sides are bringing diverse strengths to the table.

Politics 8

Politics Committee Telecommunications Diversity 8